| pubmed-article:17276686 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17276686 | lifeskim:mentions | umls-concept:C0019682 | lld:lifeskim |
| pubmed-article:17276686 | lifeskim:mentions | umls-concept:C0019699 | lld:lifeskim |
| pubmed-article:17276686 | lifeskim:mentions | umls-concept:C1522604 | lld:lifeskim |
| pubmed-article:17276686 | lifeskim:mentions | umls-concept:C0033262 | lld:lifeskim |
| pubmed-article:17276686 | lifeskim:mentions | umls-concept:C0012133 | lld:lifeskim |
| pubmed-article:17276686 | lifeskim:mentions | umls-concept:C0011209 | lld:lifeskim |
| pubmed-article:17276686 | lifeskim:mentions | umls-concept:C0220781 | lld:lifeskim |
| pubmed-article:17276686 | lifeskim:mentions | umls-concept:C0439851 | lld:lifeskim |
| pubmed-article:17276686 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:17276686 | lifeskim:mentions | umls-concept:C1883254 | lld:lifeskim |
| pubmed-article:17276686 | lifeskim:mentions | umls-concept:C1552596 | lld:lifeskim |
| pubmed-article:17276686 | lifeskim:mentions | umls-concept:C0205460 | lld:lifeskim |
| pubmed-article:17276686 | lifeskim:mentions | umls-concept:C1947931 | lld:lifeskim |
| pubmed-article:17276686 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:17276686 | pubmed:dateCreated | 2007-4-2 | lld:pubmed |
| pubmed-article:17276686 | pubmed:abstractText | Novel glycerolipidic prodrugs of didanosine and didanosine monophosphate designed to by-pass the hepatic first pass metabolism were synthesized and tested for their cytotoxicity and anti-HIV-1 activity. Formulation as liposomes of dipalmitoylphosphatidylcholine was elaborated. A simple quantitative HPLC-UV method was developed and validated, and ESI-MS was used for qualitative purpose. These two prodrugs exhibited promising biological activities against HIV-1 in in vitro infected cell culture. | lld:pubmed |
| pubmed-article:17276686 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17276686 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17276686 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17276686 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17276686 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17276686 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17276686 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17276686 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17276686 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17276686 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17276686 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:17276686 | pubmed:issn | 0960-894X | lld:pubmed |
| pubmed-article:17276686 | pubmed:author | pubmed-author:CouvreurPatri... | lld:pubmed |
| pubmed-article:17276686 | pubmed:author | pubmed-author:ClayettePasca... | lld:pubmed |
| pubmed-article:17276686 | pubmed:author | pubmed-author:VassalGillesG | lld:pubmed |
| pubmed-article:17276686 | pubmed:author | pubmed-author:Dereuddre-Bos... | lld:pubmed |
| pubmed-article:17276686 | pubmed:author | pubmed-author:DesmaëleDidie... | lld:pubmed |
| pubmed-article:17276686 | pubmed:author | pubmed-author:AndrieuxKarin... | lld:pubmed |
| pubmed-article:17276686 | pubmed:author | pubmed-author:PaciAngeloA | lld:pubmed |
| pubmed-article:17276686 | pubmed:author | pubmed-author:DeroussentAla... | lld:pubmed |
| pubmed-article:17276686 | pubmed:author | pubmed-author:RéMichelineM | lld:pubmed |
| pubmed-article:17276686 | pubmed:author | pubmed-author:LalanneMuriel... | lld:pubmed |
| pubmed-article:17276686 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17276686 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:17276686 | pubmed:volume | 17 | lld:pubmed |
| pubmed-article:17276686 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17276686 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17276686 | pubmed:pagination | 2237-40 | lld:pubmed |
| pubmed-article:17276686 | pubmed:meshHeading | pubmed-meshheading:17276686... | lld:pubmed |
| pubmed-article:17276686 | pubmed:meshHeading | pubmed-meshheading:17276686... | lld:pubmed |
| pubmed-article:17276686 | pubmed:meshHeading | pubmed-meshheading:17276686... | lld:pubmed |
| pubmed-article:17276686 | pubmed:meshHeading | pubmed-meshheading:17276686... | lld:pubmed |
| pubmed-article:17276686 | pubmed:meshHeading | pubmed-meshheading:17276686... | lld:pubmed |
| pubmed-article:17276686 | pubmed:meshHeading | pubmed-meshheading:17276686... | lld:pubmed |
| pubmed-article:17276686 | pubmed:meshHeading | pubmed-meshheading:17276686... | lld:pubmed |
| pubmed-article:17276686 | pubmed:meshHeading | pubmed-meshheading:17276686... | lld:pubmed |
| pubmed-article:17276686 | pubmed:meshHeading | pubmed-meshheading:17276686... | lld:pubmed |
| pubmed-article:17276686 | pubmed:meshHeading | pubmed-meshheading:17276686... | lld:pubmed |
| pubmed-article:17276686 | pubmed:meshHeading | pubmed-meshheading:17276686... | lld:pubmed |
| pubmed-article:17276686 | pubmed:meshHeading | pubmed-meshheading:17276686... | lld:pubmed |
| pubmed-article:17276686 | pubmed:meshHeading | pubmed-meshheading:17276686... | lld:pubmed |
| pubmed-article:17276686 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17276686 | pubmed:articleTitle | Synthesis and biological evaluation of two glycerolipidic prodrugs of didanosine for direct lymphatic delivery against HIV. | lld:pubmed |
| pubmed-article:17276686 | pubmed:affiliation | Université Paris-Sud, UMR CNRS 8612, IFR 141, F-92296 Châtenay-Malabry, France. | lld:pubmed |
| pubmed-article:17276686 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17276686 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:17276686 | lld:chembl |
